Vicore Pharma Holding Overview

  • Founded
  • 2000

Founded
  • Status
  • Public

  • Employees
  • 21

Employees
  • Stock Symbol
  • VICO

Stock Symbol
  • Investments
  • 5

  • Share Price
  • $2.96

  • (As of Thursday Closing)

Vicore Pharma Holding General Information

Description

Vicore Pharma Holding AB is a drug development company. The company's through is a subsidiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its drug candidate, C21, is the first small molecule compound in its class.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Kronhusgatan 11
  • 411 05 Gothenburg
  • Sweden
+46 031-788 00 00

Vicore Pharma Holding Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vicore Pharma Holding Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.96 $3.01 $1.33 - $3.81 $217M 71.8M 333K -$0.51

Vicore Pharma Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 152,577 59,634 191,726 49,037
Revenue 0 0 0 0
EBITDA (36,950) (34,208) (15,681) (9,740)
Net Income (36,705) (34,523) (15,928) (9,841)
Total Assets 31,358 49,854 49,556 36,484
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vicore Pharma Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vicore Pharma Holding‘s full profile, request access.

Request a free trial

Vicore Pharma Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vicore Pharma Holding AB is a drug development company. The company's through is a subsidiary is developing a new type o
Pharmaceuticals
Gothenburg, Sweden
21 As of 2022
000.00
000000000 000.00

000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
000000000000000
Lagos, Nigeria
00 As of 0000

000000

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
000000000000000
Cambridge, United Kingdom
00000 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vicore Pharma Holding Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria 00
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 00.000 00000000 00.000
You’re viewing 2 of 2 competitors. Get the full list »

Vicore Pharma Holding Executive Team (11)

Name Title Board Seat Contact Info
Carl Dalsgaard Ph.D Chief Executive Officer
Hans Jeppsson Ph.D Chief Financial Officer
Nina Carlén Chief Administrative Officer
Johan Raud Ph.D Chief Scientific Officer
Åsa Magnusson Chief Commercial Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Vicore Pharma Holding Board Members (6)

Name Representing Role Since
Bengt Falk Ph.D Self Board Member 000 0000
Hans Schikan Self Board Member 000 0000
Michael Jensen Self Chairman & Board Member 000 0000
Peter Strom Self Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Vicore Pharma Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vicore Pharma Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vicore Pharma Holding‘s full profile, request access.

Request a free trial

Vicore Pharma Holding Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (000 02-Nov-2020 000000000 00000 Buildings and Property 0000 0000
0000 000000 01-Jul-2018 0000000000 Drug Discovery 000 00000
000000000 08-Feb-2018 00000 0000 Industrial Chemicals 000 00000
000000000 01-Mar-2011 00000 0000 00.000 Industrial Chemicals 000 00000
Selektope Early Stage VC Industrial Chemicals 000 00000
To view Vicore Pharma Holding’s complete investments and acquisitions history, request access »

Vicore Pharma Holding Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 08-Feb-2018 00000 00000 00 Completed
  • 000000 000000 0000
000000000 01-Mar-2011 00000 00000 00 00.000 Completed
  • 4 buyers
Selektope Early Stage VC Completed
  • 2 buyers
To view Vicore Pharma Holding’s complete exits history, request access »